The Akkermansia Company Introduces Innovative Gut Health Supplement to the U.S. Market"
ByAinvest
Thursday, Jun 27, 2024 11:16 am ET1min read
AMZN--
The Akkermansia Company, a pioneering firm in gut health research, has made waves in the U.S. market with the launch of its first consumer product, Healthy Weight [1]. This innovative supplement combines the company's proprietary pasteurized Akkermansia muciniphila MucT™ with EGCG green tea and chromium, all proven to support weight management and overall wellness.
Akkermansia, a bacterium linked to improved gut health, had gained significant attention in recent years due to its potential benefits in addressing various health conditions [2]. In the absence of Akkermansia in the gut, weight management can become a challenge. A review by a functional medicine nutritionist shared on Metagenics revealed that a patient's weight began to decrease significantly after incorporating an Akkermansia supplement into their diet [1].
The Akkermansia Company's inventors, Cani et al., have been awarded the first US patent related to treating metabolic disorders, including obesity, through the oral administration of Akkermansia [2]. Their patent victory paves the way for the company's introduction of Healthy Weight with Glucose Control, which aims to aid in weight management and promote healthy glucose metabolism.
Healthy Weight with Glucose Control is now available through Amazon, priced at $59.99 per 30-day supply [1]. The supplement's combination of proven ingredients offers a promising solution for individuals seeking to improve their gut health and manage their weight.
References:
[1] https://www.metagenics.com/akkermansia
[2] https://www.nutritioninsight.com/news/the-akkermansia-company-pioneers-probiotic-obesity-treatment-with-us-patent-win.html
FUSB--
MGNX--
The Akkermansia Company, pioneers in gut health, has launched its first U.S. consumer product, Healthy Weight, containing Akkermansia muciniphila, a bacterium linked to improved gut health and overall wellness. The company's proprietary pasteurized Akkermansia muciniphila MucT™, proven safe and effective in human trials, is combined with EGCG Green Tea and Chromium to aid in weight management. Healthy Weight has been available in Europe since 2021 and is now available in the U.S. through Amazon for $59.99 per 30-day supply.
The Akkermansia Company, a pioneering firm in gut health research, has made waves in the U.S. market with the launch of its first consumer product, Healthy Weight [1]. This innovative supplement combines the company's proprietary pasteurized Akkermansia muciniphila MucT™ with EGCG green tea and chromium, all proven to support weight management and overall wellness.
Akkermansia, a bacterium linked to improved gut health, had gained significant attention in recent years due to its potential benefits in addressing various health conditions [2]. In the absence of Akkermansia in the gut, weight management can become a challenge. A review by a functional medicine nutritionist shared on Metagenics revealed that a patient's weight began to decrease significantly after incorporating an Akkermansia supplement into their diet [1].
The Akkermansia Company's inventors, Cani et al., have been awarded the first US patent related to treating metabolic disorders, including obesity, through the oral administration of Akkermansia [2]. Their patent victory paves the way for the company's introduction of Healthy Weight with Glucose Control, which aims to aid in weight management and promote healthy glucose metabolism.
Healthy Weight with Glucose Control is now available through Amazon, priced at $59.99 per 30-day supply [1]. The supplement's combination of proven ingredients offers a promising solution for individuals seeking to improve their gut health and manage their weight.
References:
[1] https://www.metagenics.com/akkermansia
[2] https://www.nutritioninsight.com/news/the-akkermansia-company-pioneers-probiotic-obesity-treatment-with-us-patent-win.html

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet